Covered recipient · General Payments record
SANJAY I SERRAO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,007.79
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.55 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $57.24 | 3 |
| ABBVIE INC. | $49.11 | 3 |
| DEXCOM, INC. | $47.20 | 1 |
| Exact Sciences Corporation | $44.27 | 2 |
| Novo Nordisk AS | $40.75 | 2 |
| GlaxoSmithKline, LLC. | $36.06 | 2 |
| Dynavax Technologies Corporation | $24.76 | 1 |
| Acerta Pharma LLC | $21.60 | 1 |
| Amgen Inc. | $17.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.99 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058078 | CMS |
| ABBVIE INC. | $15.69 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058080 | CMS |
| ABBVIE INC. | $14.43 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106058082 | CMS |
| Amgen Inc. | $17.56 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116103873 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.60 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104666989 | CMS |
| Dexcom, Inc. | $47.20 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153334199 | CMS |
| Dynavax Technologies Corporation | $24.76 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082150679 | CMS |
| Exact Sciences Corporation | $22.37 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134957545 | CMS |
| Exact Sciences Corporation | $21.90 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134957547 | CMS |
| GlaxoSmithKline, LLC. | $14.57 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116152116 | CMS |
| GlaxoSmithKline, LLC. | $21.49 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116203217 | CMS |
| Lilly USA, LLC | $16.28 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135388473 | CMS |
| Lilly USA, LLC | $21.68 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135343214 | CMS |
| Lilly USA, LLC | $19.28 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135392565 | CMS |
| Novo Nordisk Inc | $23.87 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096944060 | CMS |
| Novo Nordisk Inc | $16.88 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097781528 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.